What Is Clinical Oncology?

China Anti-Cancer Association Clinical Oncology Collaborative Professional Committee (CSCO) is a national professional academic group voluntarily formed by clinical oncology professionals and related enterprises and institutions.

Chinese Cancer Society Collaborative Professional Committee on Clinical Oncology

Right!

China Anti-Cancer Association Clinical Oncology Professional Committee

One. Carry out continuing education, train professional tumor prevention and treatment talents, update clinical oncology knowledge and technology, improve the academic level and business skills of the majority of clinical oncologists, encourage and support young and middle-aged scholars to actively participate in international academic exchanges, and recommend and recognize academic achievements Cancer clinician.

two. Organize and coordinate multi-center, multi-disciplinary, multi-level collaborative research in clinical oncology in accordance with GCP norms, promote clinical oncology research, promote the transformation of medical scientific research results, and promote advanced diagnostic and treatment technologies.

three. Establish close ties with relevant academic groups and tumor prevention organizations at home and abroad, actively carry out international and domestic academic exchanges, promote international scientific and technological cooperation, and promote friendly exchanges at home and abroad.

four. Collect and provide information on cancer prevention and control at home and abroad, edit and publish professional academic journals, recommend and reward outstanding academic papers and books, and support the publication of books on clinical oncology.

Fives. Actively carry out publicity and education on cancer prevention and treatment, popularize and popularize the scientific knowledge of cancer diagnosis and treatment through various publicity media and methods, and promote mass anti-cancer activities. Carry out oncology consultation services, and provide medical, nursing, rehabilitation guidance and public welfare services for oncology patients.

six. Acting as the link between the government and the health administrative department in linking cancer clinicians and assistants in carrying out cancer prevention and treatment; accepting commissions and undertaking the tumor prevention decision-making demonstrations and scientific research results identification by relevant departments.

Chapter I General Provisions

Article 1 This organization is named the Chinese Society of Anti-Cancer Association Clinical Oncology Professional Committee (Chinese SOCIETY OF CLINICAL ONGOLOGY, CSCO for short). It is an academic collaboration organization of unincorporated people voluntarily composed of clinical cancer professionals and related units nationwide.

Article 2 Purpose: Under the leadership of the Communist Party of China, adhere to the "Four Basic Principles", adhere to reform and opening up, accept the leadership and supervision of the Ministry of Health and China Anti-Cancer Association, observe discipline and law, and emphasize "unity, cooperation, and pragmatism". That is to unite and organize oncology clinicians in various related disciplines across the country to conduct multidisciplinary, multicenter, and multilevel clinical collaboration based on GCP, develop and promote advanced diagnostic and treatment technologies, and publicize and popularize anti-cancer knowledge; Combination of western medicine, modern medicine and traditional medicine, coordinate domestic research, strengthen international exchanges, continuously improve the clinical diagnosis and treatment of tumors, and promote the vigorous development of China's anti-cancer cause. "Building services.

Chapter 2 Tasks

Article 3 The main tasks of CSCO:

(1) Promote clinical research on tumors, promote advanced diagnosis and treatment technologies, organize and promote scientific and technological collaborations in compliance with GCP norms, collect and provide the latest anticancer information at home and abroad, actively carry out academic activities and technical exchanges, and edit professional academic books and periodicals.

(2) Establish close ties with relevant academic groups and anti-cancer organizations at home and abroad, actively carry out international academic exchanges and promote friendly exchanges, and carry out extensive cooperation in the field of clinical oncology.

(3) Carry out continuing education, train professional anti-cancer talents, update clinical oncology knowledge and technology, and improve the academic and professional levels of the majority of oncology clinicians; recommend and recognize advanced oncology clinicians, and recommend and reward outstanding academic papers and works And research results.

(4) Actively carry out publicity and education on cancer prevention and treatment, and popularize and popularize the scientific knowledge of cancer diagnosis and treatment through various publicity media and methods, and promote mass anti-cancer activities. Carry out cancer diagnosis and treatment consultation, organize and support tumor screening, and provide medical, nursing, rehabilitation guidance and public welfare services for cancer patients.

(5) Acting as the link between the government and the health administrative department in linking tumor clinical workers and assistants in tumor prevention and treatment, and actively providing relevant departments with good advice on tumor diagnosis, treatment, and research; accepting commissions to undertake tumor prevention decision-making demonstrations and scientific and technological project evaluations And scientific research results. Actively reflect the voice of oncology clinicians and help protect their legitimate rights and interests.

Chapter III Members

Article 4 Those who engage in oncology clinical professionals and pharmaceutical enterprises and institutions meet the basic conditions of members, are willing to abide by the Constitution of the China Anti-Cancer Association and this Regulation, and actively participate in CSCO activities. A written application is required. After the Standing Committee's approval and approval, Can become a CSCO member, issue a membership card, and enjoy corresponding rights and obligations.

Article 5: Members

(1) Individual members: Individuals with corresponding academic qualifications and basic professional qualifications. Applications are submitted by individuals. Two formal members of the Association introduce and recommend, fill out the "Individual Membership Application Form." Become a CSCO Individual Member.

(2) Honorary Members: Experts who have made important contributions to the development of China's oncology clinical cause and actively participate in and support the work of CSCOs. CSCSO members over 70 years of age can be awarded honorary members by the Standing Committee.

(3) Group members: They belong to clinical oncology-related, regular or authoritative medical institutions and academic organizations, and the applicants fill out the "group member application form". After review by the standing committee, they pay annual membership fees in accordance with regulations. Can become a member of CSCO group.

Article 6: Rights, Obligations , Rewards and Punishments of Members

(1) Members are obliged to abide by these regulations, pay dues on schedule, support and care for CSCO work, implement committee resolutions and complete tasks entrusted by CSCO, and actively participate in or assist in the development of tumor prevention activities organized by CSCO committees.

(2) Members enjoy the right to vote and be elected, have the right to suggest, supervise work, and participate in academic and public welfare activities organized by CSCO, enjoy the priority and preferential treatment provided by the Association, regularly receive academic materials from CSCO, and support from CSCO With help.

(3) Members can get CSCO recognition and rewards when they have made significant achievements or made important contributions in clinical clinical work.

(4) Members have the freedom to withdraw from the membership. The member applies for a written application, and the standing committee can approve the withdrawal procedure. If the member does not pay the membership fee for two consecutive years, it is considered to be withdrawing from the membership by itself, no longer enjoying the rights of members and fulfilling their obligations. The Commission has the right to persuade those who seriously violate the regulations or engage in illegal activities that damage CSCO's reputation until they are removed from the association.

Article 7: Rights and Obligations of Group Members

(1) Group members are obliged to abide by these regulations, pay dues on time, support and care for CSCO work, implement committee decisions and complete tasks entrusted by CSCO, and actively participate in or assist in the development of tumor prevention activities organized by CSCO committees.

(2) Group members enjoy the status of members of the Standing Committee of the Executive Committee, and have the right to recommend and supervise the work of the CSCO on the election of members of the Society.

(3) Preferential participation in relevant academic activities organized by the Society; obtaining relevant publicity and academic materials compiled by the Society; obtaining technical consulting services from the Society's experts.

(4) Payment of dues on time in accordance with regulations.

(5) Group members have the freedom to withdraw from the membership. The company submits a written application and the standing committee can approve the withdrawal. If the group member does not pay the membership fee for 1 year, it is considered to be withdrawing from the membership by itself, no longer enjoying the rights of members and fulfilling their obligations. The Commission has the right to persuade those who violate the regulations or engage in illegal activities that damage CSCO's reputation until they are removed from the membership.

Chapter IV Birth and Removal of Organizations and Persons in Charge

Article 8 The principle of CSCO organization is democratic centralism, and the highest authority is the National Member Congress, which is generally held every two years. Member representatives are composed of elected representatives, group member representatives and specially invited representatives from various places. The congress discusses and decides CSCO's working principles and tasks, formulates and revises the charter, reviews the committee's work report, adopts proposals and resolutions, elects new committee members, and reports to the China Anti-Cancer Association for review and filing.

Article 8 The Committee is the leading body during the closing period of the National Congress of Members. The members shall be elected through secretive and democratic consultations and by secret ballot. Their responsibilities are: to implement the resolutions of the member congress, to formulate and review work plans, to determine the establishment of functional departments, and to organize the election of CSCO leaders and standing committee leaders for various academic activities , To supervise the revenue and expenditure of funds, recommend and praise outstanding. The committee meets twice a year.

Article 9 : The Standing Committee shall be composed of one CSCO chairman, several deputy chairman members, one secretary general, several deputy secretary generals, and several standing members elected by the committee. The chairman and deputy directors cannot serve for more than two consecutive terms, but they can be re-elected every other term. During the Committee's adjournment, the Standing Committee exercises its powers as a standing executive body. The Standing Committee meets once a year and may be convened temporarily when necessary.

Article 10: The Steering Committee is established by a well-known expert nationwide, who has made great contributions to the development of clinical oncology in China and still insists on clinical work, but has exceeded the legal working age of the country as the steering committee and set up a chairman. The steering committee members have the rights and responsibilities of standing committee members, and have the right to guide, supervise, criticize and suggest CSCO work.

Article 11: During the adjournment of the Standing Committee, the chairman will preside over and lead the overall work of the CSCO, and the secretary general will be responsible for implementing the resolutions of the standing committee and handling the daily conference affairs under the leadership of the chairman. This office has an office, a secretariat, and several functional working departments. Some standing members or members (including steering members) are responsible for division of labor, and the secretary-general guides and coordinates. According to the needs of academic activities, as determined by the committee, several professional study groups may be established when necessary.

Article 12: Upon the nomination of the chairman of the Association, the committee can adopt outstanding individuals with outstanding reputation and major contributions to China's anti-cancer cause as honorary chairman of the Association. Can also hire internationally renowned clinical oncology experts as CSCO correspondence members or honorary members.

Chapter V Funding

Article 13 The sources of CSCO funding are: membership dues, donations from individuals or groups enthusiastic about anti-cancer causes, scientific and technological development, and consulting service income.

Article 14 Fund Management: Establish a financial management system under the leadership of the Standing Committee. Fund revenues and expenditures shall be strictly implemented in accordance with the state's relevant financial and economic regulations on science and technology associations. They must be used for the activities and development of the Association. The committee, the director, and the secretary-general's office have requested instructions to report and accept financial supervision and audit by the China Cancer Society.

Chapter VI Supplementary Provisions

Article 15 The CSCO office address is located in Beijing. Design and develop a unified emblem logo in accordance with the purpose of the Organization.

Article 16 Termination Procedure: When the Association needs to terminate its activities, it shall be discussed and approved by the Standing Committee, a temporary national member congress shall be convened, and only after obtaining a two-thirds majority consent and submitting it to the China Anti-Cancer Association for approval and consent, can it do Dissolution decision.

Article 17: This Article of Association shall come into effect on the date of discussion and adoption of the National Congress of Members and shall be reported to the Ministry of Health for the record and the power of interpretation shall be vested in the Standing Committee.

^[2]